White matter damage in patients with mild cognitive impairment in Parkinson's disease

被引:6
作者
Li, Qian-Qian [1 ]
Wu, Ke [1 ]
Xu, Jia-Li [2 ]
Yin, Liang [1 ]
机构
[1] Bengbu Med Coll, Afliated Hosp 1, Dept Neurol, 287 Changhuai Rd, Bengbu 233004, Peoples R China
[2] Bengbu Med Coll, Afliated Hosp 1, Dept Imaging, Bengbu, Peoples R China
关键词
Parkinson's disease (PD); early cognitive impairment; white matter damage; diffusion tensor imaging; Montreal Cognitive Assessment scale; DIAGNOSTIC-CRITERIA; DEMENTIA;
D O I
10.21037/qims-21-579
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: This study investigates the correlation between white matter structural damage and cognitive impairment in patients with Parkinson's disease (PD) and mild cognitive impairment (MCI). Methods: A total of 40 patients with PD were divided into two groups, i.e., a mild cognitive impairment (PD-MCI) and a normal cognitive (PDN) group, and 20 healthy patients were enrolled as the control group. Changes in the white matter structure of patients with PD were evaluated using diffusion tensor imaging (DTI), and cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA) scale and Mini-Mental State Examination (MMSE). Finally, the correlations between the two groups were analyzed. Results: The Unified Parkinson's Disease Rating Scale score was significantly higher in the PD-MCI than in the PDN group (P=0.008). The total MoCA and MMSE scores in the PD-MCI group were significantly lower than in the PDN and control groups (P<0.01). Patients in PDMCI group were tested by MMSE scale, and the abnormal score rate was 60.0%. Among them, 8 PD patients with normal MMSE total score were found to have mild cognitive impairment by MoCA evaluation. When compared with the PDN and control groups, the MoCA scores for visual space, which is assessed as part of the MoCA scale and generally represents bilateral parietal function; naming; memory; and attention were significantly lower in the PDMCI group (P<0.001). When compared with the PDN group, the fractional anisotropy (FA) values for the right parietal and left occipital lobes were significantly lower in the PD-MCI group (P=0.005; P=0.018). The relationship between MoCA value and right parietal white matter and left occipital white matter was 0.555, 0.474, respectively. A Pearson's correlation test was conducted to compare the FA values and MoCA scores of the various brain areas in the PD-MCI group and revealed a significant positive correlation between the MoCA score and the white matter of the right parietal and left occipital lobes (P<0.01). Conclusions: Patients with PD experience early cognitive impairment, and the MoCA scale can be used for early screening. In addition, the DTI of white matter can highlight early white matter damage. In the current study, the damaged brain areas displayed by DTI were consistent with areas showing decreased MoCA scores and were positively correlated with the severity of PD.
引用
收藏
页码:1290 / 1298
页数:9
相关论文
共 50 条
  • [31] Cognitive Characteristics Associated with Mild Cognitive Impairment in Parkinson's Disease
    McKinlay, A.
    Grace, R. C.
    Dalrymple-Alford, J. C.
    Roger, D.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (02) : 121 - 129
  • [32] Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting Mild Cognitive Impairment in Parkinson's Disease
    Zhang, Zuowen
    Li, Shishuang
    Wang, Shumei
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 785 - 792
  • [33] Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease
    Chen, Fu-Xiang
    Kang, De-Zhi
    Chen, Fu-Yong
    Liu, Ying
    Wu, Gang
    Li, Xun
    Yu, Liang-Hong
    Lin, Yuan-Xiang
    Lin, Zhang-Ya
    NEUROSCIENCE LETTERS, 2016, 617 : 160 - 165
  • [34] Mild cognitive impairment in Parkinson’s disease
    Amos D. Korczyn
    Journal of Neural Transmission, 2013, 120 : 517 - 521
  • [35] Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?
    Martinez-Horta, Sauel
    Kulisevsky, Jaime
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (08) : 1185 - 1190
  • [36] Evaluation of Mild Cognitive Impairment Subtypes in Parkinson's Disease
    Cholerton, Brenna A.
    Zabetian, Cyrus P.
    Wan, Jia Y.
    Montine, Thomas J.
    Quinn, Joseph F.
    Mata, Ignacio F.
    Chung, Kathryn A.
    Peterson, Amie
    Espay, Alberto J.
    Revilla, Fredy J.
    Devoto, Johnna
    Watson, G. Stennis
    Hu, Shu-Ching
    Leverenz, James B.
    Edwards, Karen L.
    MOVEMENT DISORDERS, 2014, 29 (06) : 756 - 764
  • [37] Dementia and mild cognitive impairment in Parkinson's disease: a review
    Bocanegra, Yamile
    Trujillo-Orrego, Natalia
    Pineda, David
    REVISTA DE NEUROLOGIA, 2014, 59 (12) : 555 - U60
  • [38] Mild Cognitive Impairment in Parkinson's Disease-What Is It?
    Weil, Rimona S.
    Costantini, Alyssa A.
    Schrag, Anette E.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (04)
  • [39] Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment
    Sumbul-Sekerci, Betul
    Hanagasi, Hasmet A.
    Bilgic, Basar
    Tufekcioglu, Zeynep
    Gurvit, Hakan
    Emre, Murat
    ACTA NEUROLOGICA BELGICA, 2023, 123 (03) : 823 - 829
  • [40] Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study
    Kawashima, Shoji
    Matsukawa, Noriyuki
    BMC NEUROLOGY, 2022, 22 (01)